Dr. Martens plc
DOCS.L · LSE
9/30/2025 | 3/31/2025 | 3/30/2025 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | £322,000 | – | £463,000 | £324,600 |
| % Growth | – | – | 42.6% | – |
| Cost of Goods Sold | £146,300 | – | £159,000 | £116,900 |
| Gross Profit | £175,700 | – | £304,000 | £207,700 |
| % Margin | 54.6% | – | 65.7% | 64% |
| R&D Expenses | £0 | – | £0 | £0 |
| G&A Expenses | £0 | – | £0 | £0 |
| SG&A Expenses | £172,400 | – | £155,600 | £222,800 |
| Sales & Mktg Exp. | £0 | – | £0 | £0 |
| Other Operating Expenses | £0 | – | £77,200 | £0 |
| Operating Expenses | £172,400 | – | £232,800 | £222,800 |
| Operating Income | £3,300 | – | £71,200 | -£15,100 |
| % Margin | 1% | – | 15.4% | -4.7% |
| Other Income/Exp. Net | -£14,300 | – | -£33,700 | -£13,600 |
| Pre-Tax Income | -£11,000 | – | £37,500 | -£28,700 |
| Tax Expense | -£1,000 | – | £12,200 | -£7,900 |
| Net Income | -£10,000 | – | £25,300 | -£20,800 |
| % Margin | -3.1% | – | 5.5% | -6.4% |
| EPS | -0.01 | – | 0.026 | -0.022 |
| % Growth | – | – | 219.5% | – |
| EPS Diluted | -0.01 | – | 0.026 | -0.022 |
| Weighted Avg Shares Out | 965,666 | – | 961,772 | 945,455 |
| Weighted Avg Shares Out Dil | 965,666 | – | 963,847 | 945,455 |
| Supplemental Information | – | – | – | – |
| Interest Income | £1,700 | – | £2,100 | £0 |
| Interest Expense | £14,100 | – | £16,600 | £13,500 |
| Depreciation & Amortization | £34,600 | – | £61,900 | £10,600 |
| EBITDA | £37,700 | – | £115,000 | -£4,500 |
| % Margin | 11.7% | – | 24.8% | -1.4% |